drugset / Trial / NCT00511472

An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)

NCT00511472

Phase 1 Completed 70 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to assess safety, pharmacokinetics (PK), and pharmacodynamics (PD) of MK-0941 in Type 2 diabetics being treated with basal insulin.

Timeline

Start
2007-07
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-0941 Small molecule 10 mg
Background insulin glargine Protein / enzyme biologic